The EMEA favorable reception was based on the results of a double-blind, placebo-controlled room of 278 patients with PAH. Patients were randomized to trio different dosages of soft tab viagra (20 mg, 40 mg, or 80 mg) tierce indication a day or medication. All threesome tending groups showed statistically significant improvements in the coil endpoint of six-minute walk length. No significant differences were observed between the III dosages in six-minute walk interval, thus the approved dose is limited to 20 mg trio meter daily. Patients taking Revatio also showed statistically significant improvements in other important measures of cardiac occasion. Patients were followed for an additional year as part of an open-label public exposure run. Improvements in walk part and cardiac social gathering were preserved, with Revatio patients show a 96 percent aliveness rate, compared to an expected natural action rate of 71 percent. Revatio was generally well tolerated at all doses.
This is a part of article The EMEA favorable reception. Taken from "Soft Tab Viagra" Information Blog
Thursday, December 13, 2007
The EMEA favorable reception.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment